"We Envision Growth Strategies Most Suited
to Your Business"

Medical Imaging Market to Surge at a CAGR of 6.4% over 2025 to 2032; Siemens Healthineers AG Secured FDA Approval for its MAGNETOM Cima.X 3 Tesla (3T) Scanner to Gain a Competitive Edge

March 27, 2025 | Healthcare

The global medical imaging market size stood at USD 41.91 billion in 2024. The market value is slated to rise from USD 44.33 billion in 2025 to USD 68.43 billion by 2032 at a CAGR of 6.4% during 2025-2032. Fortune Business Insights™ presents this information in its report titled “Medical Imaging Market Size, Share & Industry Analysis, By Type (Magnetic Resonance Imaging, Computed Tomography, X-ray, Ultrasound, and Molecular Imaging), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology, and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2025-2032”.

Medical imaging technology deploys numerous imaging modalities for obtaining the images of body interior for therapeutic and diagnostic purposes. The rising government emphasis on early disease diagnosis for controlling healthcare costs is poised to open doors to new opportunities for industry players. Around 3.6 billion diagnostic procedures are performed at the global level on an annual basis, according to the World Health Organization.

During the COVID-19 pandemic, the decline in hospital visits resulted in a drop in the revenues of several industry players in 2020 compared to 2019.

Siemens Healthineers AG Announced FDA Approval of the MAGNETOM Cima.X 3 Tesla (3T) Scanner to Gain Strong Market Foothold

In January 2024, Siemens Healthineers AG announced the approval of the U.S. FDA (Food and Drug Administration) for its MAGNETOM Cima.X 3 Tesla (3T) magnetic resonance imaging (MRI) whole-body scanner. The solution has been equipped with new features for addressing key imaging challenges and improving scientific research.

Rising Prevalence of Chronic Disorders to Impel Industry Growth

A surge in the prevalence of chronic diseases is a key factor anticipated to propel medical imaging market growth. An increase in sedentary lifestyle and escalating geriatric population are augmenting the prevalence of ailments such as dementia, cancer, and Alzheimer’s disease. The soaring demand for accurate and early disease diagnosis is touted to boost industry expansion.

The expenses associated with advanced imaging equipment may, nonetheless, create challenges for market growth.

Competitive Landscape

Presence of strong distribution networks and portfolio diversification are some of the key steps adopted by leading companies to strengthen their industry positions. They are also introducing advanced equipment. A few of the major industry players comprise Philips and Hologic Inc.

Key Players Profiled in the Report

  • General Electric (U.S.)
  • Hitachi, Ltd. (Japan)
  • Shimadzu Corporation (Japan)
  • Siemens Healthineers AG (Germany)
  • Koninklijke Philips N.V. (Netherlands)
  • Hologic, Inc. (U.S.)
  • Samsung (South Korea)
  • Fujifilm Holdings Corporation (Japan)  

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/medical-imaging-equipment-market-100382

Key Industry Development

  • December 2022 – Koninklijke Philips N.V. introduced a new Ultrasound Compact System 5000 Series. The series has been claimed to offer premium image quality required for an apt diagnosis in a portable unit.

Further Report Findings

  • Market players are anticipated to witness lucrative growth opportunities in the Asia Pacific region owing to an aging and large base of medical imaging equipment. The regional market is touted to expand at the highest growth rate over 2025 to 2032.
  • The presence of well-established healthcare units is poised to boost industry expansion in Europe. The market is set to exhibit a significant CAGR over the analysis period with several industry participants keen on securing regulatory approvals for their medical imaging equipment.
  • Based on type, the market is categorized into computed tomography, magnetic resonance imaging, x-ray, ultrasound, and molecular imaging. The X-ray segment bagged a leading market share in 2024 with an increase in product demand and escalating advancements in C-arms.
  • Based on application, the market is subdivided into neurology, cardiology, orthopedics, oncology, gynecology, and others. A rise in the adoption of medical imaging equipment in healthcare establishments for orthopedic injuries is anticipated to propel orthopedics segment growth. The segment registered a prominent medical imaging market share in 2024.
  • By end user, the market is divided into hospitals, diagnostic imaging centers, specialty clinics, and others. The rising number of diagnostic imaging centers drives the dominance of this segment. The U.S. has over 6,000 IDTFs (Independent Diagnostic Testing Facilities) within the outpatient segment, according to HealthCare Appraisers, Inc.

Table of Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.4% from 2025-2032

Unit

Value (USD Billion), ASP (USD), and Volume (Units)

 

 

 

 

 

 

 

 

 

 

Segmentation

By Type

  • Magnetic Resonance Imaging
  • Computed Tomography
  • X-ray
  • Ultrasound
  • Molecular Imaging

By Application

  • Cardiology
  • Neurology
  • Orthopedics
  • Gynecology
  • Oncology
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, By Application, By End User, and by Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By End User, and by Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By End User, and by Country)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By End User, and by Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By End User, and by Country)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Healthcare
  • PDF
  • 2024
  • 2019 - 2023
  • 261

    CHOOSE LICENSE TYPE

  • 4850
    5850
    6850

Our Clients

 Kpmg
 LG Chem
 Mckinsey
 Mobil
 uniliver